US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Prescription Drugs: market research reports

RSS Feeds

Prescription Drugs market research reports and industry analysis

  2    4  5  6  7  8  9  10  
Pharmaceuticals and Healthcare Report - Chile Q3 2014
7/2/2014 | published by: Business Monitor International
... of insurance and clinicmanagement business units. Chile's slightly deteriorating business environment will also put pressure onfuture financial performance. Multinationals will also face further challenges due to the promotion ofgeneric drug usage in Chile. Headline Expenditure ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Ireland Q3 2014
7/2/2014 | published by: Business Monitor International
... Ireland as one of the highest in Europe. This will have a knock-on effect on government pharmaceutical expenditure, and means that companiesoperating in the country will face ongoing revenue-restricting measures. Meanwhile, we believe the worstof ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - United States Q3 2014
7/2/2014 | published by: Business Monitor International
... is unparalleled, spending power isgrowing at a sustainable rate, innovative medicines are adopted rapidly and corporate activity is intense.The key risk to our outlook is downward pricing pressure, mainly from health insurers and pharmacybenefit managers. ...  |  read more...
USD 1,295
Contraception - Pipeline Review, H1 2014
6/30/2014 | published by: Global Markets Direct
... Contraception, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Pharmaceuticals and Healthcare Report - Russia Q3 2014
6/25/2014 | published by: Business Monitor International
... of the Crimeacrisis, as the government wishes to end its reliance on imports and have more direct control over itspharmaceutical supply. Over the longer term, the country's ageing population and significant diseaseburden will act to ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Finland Q3 2014
6/25/2014 | published by: Business Monitor International
... we believe the success of the annual decline in reimbursed medicine prices will result in thegovernment maintaining the generic reference pricing system that is in place. Amplifying price pressures onpatented medicines are the unsystematic price ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Israel Q3 2014
6/25/2014 | published by: Business Monitor International
... on pharmaceutical prices as a way tocontain escalating healthcare costs. Overall, Israel's pharmaceutical industry is well developed and exportdriven. It is also a very attractive prospect for multinationals looking to launch innovative medicines due toa ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - United Kingdom Q3 2014
6/25/2014 | published by: Business Monitor International
... beyond 2014. This drop in spendingreflects the UK government's focus on containing costs within the healthcare sector, and in particularpharmaceutical expenditure. Headline Expenditure Projections Pharmaceuticals: GBP23.32bn (USD36.15bn) in 2013 to GBP22.90bn (USD37.33bn) in 2014;-1.8% in ...  |  read more...
USD 1,295
Global Alzheimer's Drugs Market 2014-2018
6/20/2014 | published by: TechNavio - Infiniti Research Ltd.
... Laboratories Inc., Janssen Pharmaceuticals Inc., Novartis AG, Adamas Pharmaceuticals Inc., Archer Pharmaceuticals Inc., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., FORUM Pharmaceuticals Inc., H. Lundbeck A/S, Merck & Co., Inc., MorphoSys AG, Otsuka Pharmaceutical ...  |  read more...
USD 3,000
Pharmaceuticals and Healthcare Report - Philippines Q3 2014
6/18/2014 | published by: Business Monitor International
... with the country's relatively strong economic growth and political stability, will boostpharmaceutical consumption. Headline Expenditure Projections Pharmaceuticals: PHP138.45bn (USD3.20bn) in 2013, rising to PHP143.55bn (USD3.26bn) in 2014;+3.7% in local currency terms and +1.8% in US ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Saudi Arabia Q3 2014
6/18/2014 | published by: Business Monitor International
... as well as make the country amore attractive destination for medical tourisms. More stringent pharmaceutical regulatory policies andincreasing local production will benefit multinational drugmakers' long-term development in the country. Headline Expenditure Projections Pharmaceuticals: SAR22.70bn (USD6.06bn) ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Zimbabwe Q3 2014
6/18/2014 | published by: Business Monitor International
... Zimbabwe continues to have one of the highest Country and Industry Risks scores in the region, and thelack of foreign investment affects its ability to import significant amounts of active pharmaceuticalingredients, which are necessary for ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Bahrain Q3 2014
6/18/2014 | published by: Business Monitor International
... a Gulf CooperationCouncil decision to unify the cost of medication in the region and will eventually give rise to cheaperhospital treatments across the country. The demand for medicines will remain driven by the country'sageing population, ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Egypt Q3 2014
6/18/2014 | published by: Business Monitor International
... the past few years. Key challenges facing multinational companies include a restrictive medicine pricing regime, a lack ofregulatory data protection and poor patent enforcement. Domestic companies are meanwhile impaired by aweakened currency, which restricts their ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Iran Q3 2014
6/18/2014 | published by: Business Monitor International
... the rial means thatwe expect the value of the market to contract sharply in US dollar terms. On a positive note, improvedinternational relations have reduced the political risk associated with operating in the market formultinational ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Uzbekistan Q3 2014
6/18/2014 | published by: Business Monitor International
... However, very littledevelopment of either the pharmaceutical or healthcare sectors can be seen domestically, and we stress thatimprovement to both of these must be made if investors are to see Uzbekistan as a viable opportunity. ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - India Q3 2014
6/18/2014 | published by: Business Monitor International
... a series of patent disrespect issues. We maintain that low government spending onhealthcare is the root of the problem, as it limits patients' access to services. However, we do not expect thesituation to improve in ...  |  read more...
USD 1,295
Dermatologicals - the Czech Republic
6/16/2014 | published by: Euromonitor International
... of the VAT increase in January 2013 when value-added tax for drugs was increased by one percentage point to 15%. Retailers and distributors in anticipation of the VAT rise had postponed price increases in the ...  |  read more...
USD 900
Pharmaceuticals and Healthcare Report - Belarus Q3 2014
6/11/2014 | published by: Business Monitor International
... escalating trade war with Russia. If Russo-Belarusian relations cannot be patched up, state revenues are set to decline considerably, the net exports deficit will widen significantly and real GDP growth will decline. There are downside ...  |  read more...
USD 1,295
Pharmaceutical Wholesalers (European) - Industry Report
6/10/2014 | published by: Plimsoll Publishing Ltd.
... AVENTIS FRANCE and UNITED DRUG PUBLIC LIMITED COMPANY. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Pharmaceutical Wholesalers (European) analysis is ideal for anyone ...  |  read more...
USD 1,200
Pharmaceutical Wholesalers (Global) - Industry Report
6/10/2014 | published by: Plimsoll Publishing Ltd.
... HOLDINGS CO., LTD.. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Pharmaceutical Wholesalers (Global) analysis is ideal for anyone wanting to: See the market ...  |  read more...
USD 1,425
Pharma-Patient Engagement: insights from patient opinion leaders
6/10/2014 | published by: FirstWord
... fund more research. So, they are natural bedfellows....? Patient pressure and influence across the range of Pharma's activities is growing. While Patient Advocacy Groups are well established, there is a new breed of patient, empowered ...  |  read more...
USD 495
Pharmaceutical Wholesalers (Nordic) - Industry Report
6/10/2014 | published by: Plimsoll Publishing Ltd.
... AS. This report (compiled in English language) includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Pharmaceutical Wholesalers (Nordic) analysis is ideal for anyone wanting to: See ...  |  read more...
USD 1,050
Antobiotic Manufacturers (Global) - Industry Report
6/10/2014 | published by: Plimsoll Publishing Ltd.
... SQUIBB. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Antobiotic Manufacturers (Global) analysis is ideal for anyone wanting to: See the market leaders Identify ...  |  read more...
USD 1,425
Pharmaceuticals and Healthcare : Peru Pharmaceuticals and Healthcare Report Q3 2014
6/4/2014 | published by: Business Monitor International
... the country due to the lack of a mandatorymedicine pricing system in the country. More stringent quality control, a relatively weak domesticpharmaceutical industry, the ongoing liberalisation of bilateral trade agreements and the healthcare reformas well ...  |  read more...
USD 1,295
  2    4  5  6  7  8  9  10